Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase 3 Gene Therapy for Painful Diabetic Neuropathy

ClinicalTrials.gov ID: NCT02427464

Public ClinicalTrials.gov record NCT02427464. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT02427464
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Helixmith Co., Ltd.
Industry
Enrollment
507 participants

Conditions and interventions

Interventions

  • Engensis (VM202) Biological
  • placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2016
Primary completion
Mar 31, 2019
Completion
Mar 31, 2019
Last update posted
Oct 8, 2025

2016 – 2019

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85023
Clinical Trials, Inc. Little Rock Arkansas 72205
Richard S. Cherlin, MD Los Gatos California 95032
Northern California Research Sacramento California 95821
Center for Clinical Research San Francisco California 94115
Neurological Research Institute Santa Monica California 90404
Diablo Clinical Research, Inc. Walnut Creek California 94598
Associated Neurologists of Southern Connecticut, PC Fairfield Connecticut 06824
Innovative Research of West Florida Clearwater Florida 33756
University of Florida McKnight Brain Institute Gainesville Florida 32611
UF Health College of Med, Jacksonville Jacksonville Florida 32207
Compass Research, LLC Orlando Florida 32806
Clinical Research of West Florida Tampa Florida 33603
Northwestern University Chicago Illinois 60611
University of Kansas Medical Center Research Institute Kansas City Kansas 66160
The Brigham and Women's Hospital Boston Massachusetts 02115
University of Minnesota Minneapolis Minnesota 55455
Columbia University Medical Center Department of Neurology New York New York 10032
Raleigh Neurology Associates, P.A. Raleigh North Carolina 27607
Martin Foot and Ankle York Pennsylvania 17402
Nerve and Muscle Center of Texas Houston Texas 77030
University of Utah -Neurology Salt Lake City Utah 84132
EVMS (Eastern Virginia Medical School) Norfolk Virginia 23510
Western Washington Medical Group Everett Washington 98208
Rainier Clinical Research Center, Inc. Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02427464, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02427464 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →